agilon health, inc. (AGL) FY2026 YTD Q2 Statement of Cash Flows

Statement of Cash Flows

2026-01-01 to 2026-06-30

Swipe to see the full flow
agilon health, inc. cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026One connected Sankey reconciles operating, investing and financing net cash flows through a shared cash pool, from beginning cash to ending cash. Ribbons flow left to right on one dollar scale. Activity totals are dark gray; beginning and ending cash are blue. Cash basis for beginning and ending balances and net cash change: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations. Intermediate calculation bars are lighter gray. Net income is green for profit and red for loss. Identified asset purchases, sales and maturities are blue in either cash direction. Purple identifies capital transactions such as borrowing, repayments, share issuance and dividends. Free cash flow is a separate comparison, not an added cash flow. Read chart description and values below for full signed amounts, including zero items.Proceeds from maturities of marketable securities and other → investing reconciliation: $46,616,000.00investing reconciliation → Net cash from investing activities: $39,183,000.00investing reconciliation → Purchases of property, equipment, and capitalized software: $6,548,000.00investing reconciliation → Purchase of intangible assets: $885,000.00Proceeds from (payments for) equity issuances, net → financing reconciliation: $4,596,000.00Net cash used in financing activities → financing reconciliation: $516,000.00financing reconciliation → Repayments of long-term debt: $3,500,000.00financing reconciliation → Debt issuance costs: $1,612,000.00Net cash used in operating activities → operating reconciliation: $33,569,000.00Net income (loss) → operating reconciliation: $66,872,000.00Stock-based compensation expense → operating reconciliation: $30,087,000.00Depreciation and amortization → operating reconciliation: $13,651,000.00Other, net → operating reconciliation: $1,377,000.00operating reconciliation → Changes in operating assets and liabilities: $122,419,000.00operating reconciliation → Adjustments on sale of assets, net: $19,000,000.00operating reconciliation → Loss (income) from equity method investments: $4,137,000.00Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations → Cash sources and uses: $173,713,000.00Net cash from investing activities → Cash sources and uses: $39,183,000.00Cash sources and uses → Ending cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $178,811,000.00Cash sources and uses → Net cash used in financing activities: $516,000.00Cash sources and uses → Net cash used in operating activities: $33,569,000.00Net income (loss): $66,872,000.00Net income (loss)+$66.87 MDepreciation and amortization: $13,651,000.00Depreciation & amortization+$13.65 MStock-based compensation expense: $30,087,000.00Stock-based compensation+$30.09 MLoss (income) from equity method investments: -$4,137,000.00Equity-method results−$4.14 MAdjustments on sale of assets, net: -$19,000,000.00Asset disposal gain & loss−$19.00 MOther, net: $1,377,000.00Other non-cash items+$1.38 MChanges in operating assets and liabilities: -$122,419,000.00Operating capital changes−$122.42 MNet cash used in operating activities: -$33,569,000.00. Cash required to fund net payments.Operating cash−$33.57 Moperating reconciliation: $145,556,000.00Proceeds from (payments for) equity issuances, net: $4,596,000.00Treasury shares, net+$4.60 MDebt issuance costs: -$1,612,000.00Debt issuance costs−$1.61 MRepayments of long-term debt: -$3,500,000.00Long-term debt repaid−$3.50 MNet cash used in financing activities: -$516,000.00. Cash required to fund net payments.Financing cash−$516.00 Kfinancing reconciliation: $5,112,000.00Purchases of property, equipment, and capitalized software: -$6,548,000.00PP&E purchases−$6.55 MPurchase of intangible assets: -$885,000.00Intangible asset purchases−$885.00 KInvestment in loans receivable and other: $0.00Investments in marketable securities: $0.00Proceeds from maturities of marketable securities and other: $46,616,000.00AFS securities proceeds+$46.62 MNet cash from investing activities: $39,183,000.00Investing cash+$39.18 Minvesting reconciliation: $46,616,000.00Cash sources and uses: $212,896,000.00Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $173,713,000.00Beginning cash$173.71 MEnding cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations: $178,811,000.00Ending cash$178.81 MCASH RECONCILIATIONInvestingflowsFinancingflowsOperatingflowsFree cash flow−$40.12 MOperating cash − cash spent on PP&ECash flow / Net income−0.50×Operating cash flow ÷ net incomeNet cash change+$5.10 MEnding cash − beginning cash
Chart details

agilon health, inc. cash flow reconciliation, Jan 1, 2026 through Jun 30, 2026

Cash flows for Jan 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations. Beginning cash: Dec 31, 2025. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

Beginning cash on Dec 31, 2025
173,713,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations
Operating activities
negative 33,569,000 US dollars. Net cash used.
Net income (loss)
66,872,000 US dollars
Depreciation and amortization
13,651,000 US dollars
Stock-based compensation expense
30,087,000 US dollars
Loss (income) from equity method investments
negative 4,137,000 US dollars
Adjustments on sale of assets, net
negative 19,000,000 US dollars
Other, net
1,377,000 US dollars
Changes in operating assets and liabilities
negative 122,419,000 US dollars
Investing activities
39,183,000 US dollars. Net cash provided.
Purchases of property, equipment, and capitalized software
negative 6,548,000 US dollars
Purchase of intangible assets
negative 885,000 US dollars
Investment in loans receivable and other
0 US dollars
Investments in marketable securities
0 US dollars
Proceeds from maturities of marketable securities and other
46,616,000 US dollars
Financing activities
negative 516,000 US dollars. Net cash used.
Proceeds from (payments for) equity issuances, net
4,596,000 US dollars
Debt issuance costs
negative 1,612,000 US dollars
Repayments of long-term debt
negative 3,500,000 US dollars
Operating adjustment reconciliation
145,556,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
financing gross reconciliation
5,112,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
investing gross reconciliation
46,616,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
Exchange-rate effect
0 US dollars
Ending cash on Jun 30, 2026
178,811,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations
Cash sources and uses
212,896,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
Net cash change
5,098,000 US dollars. Ending cash minus beginning cash.
Cash flow / Net income
−0.50×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
Operating cash flow
negative 33,569,000 US dollars. Operating cash flow used in the free cash flow calculation.
Cash purchases of property, plant and equipment
6,548,000 US dollars. These cash purchases are already included in investing activities above.
Free cash flow
negative 40,117,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

Chart connections

  • Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
  • Financing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Investing contributions meet at a reconciliation junction before connecting to the net cash total.
  • Operating reconciliation adjustments are not all independent cash receipts.
  • Net income or operating cash is negative. The full signed reconciliation is retained: losses remain deductions, and any negative operating-cash total enters the junction from the cash pool. No positive direct-income connection is implied.
  • Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
  • The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
  • Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: negative 33,569,000 US dollars minus 6,548,000 US dollars equals negative 40,117,000 US dollars.
agilon health, inc. (AGL) FY2026 YTD Q2 Statement of Cash Flows Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!